|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Cash flows from operating activities: | ||
| Net loss | ||
| Adjustment to reconcile net loss to net cash used in operating activities: | ||
| Stock-based compensation expense | ||
| Amortization/Accretion of bond discounts/premiums | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses and other current assets | ||
| Other assets | ||
| Accounts payable | ||
| Accrued expenses | ||
| Operating lease liabilities | ||
| Net cash used in operating activities | ||
| Cash flows from investing activities: | ||
| Purchase of short-term investments | ||
| Maturity of short-term investments | ||
| Purchase of short-term and long-term investments | ||
| Sales and maturities of short-term and long-term investments | ||
| Net cash used in investing activities | ||
| Cash flows from financing activities: | ||
| Proceeds from issuance of common stock in an initial public offering, net of issuance costs | ||
| Proceeds from issuance of common stock, net of issuance costs | ||
| Proceeds from the exercise of stock options | ||
| Payment of deferred financing costs | ||
| Net cash provided by financing activities | ||
| Net decrease in cash and cash equivalents | ||
| Cash and cash equivalents at beginning of the year | ||
| Cash and cash equivalents at end of the year | ||
| Supplemental disclosures of non-cash financing and investing activities | ||
| Deferred offering costs transferred to additional paid-in-capital |
Loading...
